Byrne Asset Management LLC Moderna, Inc. Transaction History

Byrne Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 21, 2023	BUY	$118.5 - $160.53 $41,949 - $56,827	354 Added 51.68%	1,039 $126,000
Q1 2023 Apr 17, 2023	SELL	$135.66 - $197.02 $2,441 - $3,546	-18 Reduced 2.56%	685 $105,000
Q4 2022 Jan 30, 2023	SELL	$118.38 - $210.04 $21,900 - $38,857	-185 Reduced 20.83%	703 $126,000
Q3 2022 Oct 19, 2022	SELL	$118.07 - $194.18 $7,438 - $12,233	-63 Reduced 6.62%	888 $105,000
Q2 2022 Jul 20, 2022	SELL	$117.13 - $176.59 $8,433 - $12,714	-72 Reduced 7.04%	951 $136,000
Q1 2022 Apr 05, 2022	SELL	$126.46 - $235.05 $25,165 - $46,774	-199 Reduced 16.28%	1,023 $176,000
Q4 2021 Feb 22, 2022	BUY	$225.82 - $368.51 $275,952 - $450,319	1,222 New	1,222 $310,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Byrne Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Byrne Asset Management LLC with notifications on news.